Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EUROCELL PLC Major Shareholding Notification 2018

Nov 1, 2018

4926_mrq_2018-11-01_93ccb029-8896-4894-9ae4-c6d31c7f11d6.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0308G

Eurocell plc

01 November 2018

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached: ii
EUROCELL PLC
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights ü
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the

notification obligation: iii
Santander Asset Management UK
4. Full name of shareholder(s)

 (if different from 3.):iv
Santander N&P UK Growth Unit Trust, 

Santander Max 70% Shares Unit Trust,

Santander UK Growth Unit Trust;

Santander Equity Income Unit Trust;

Santander Dividend Income;

Santander Max 30% Shares Income Portfolio;

Santander Enhanced Income Portfolio;

 and Santander Premium Fund UK Equities
5. Date of the transaction and date on

which the threshold is crossed or

reached: v
08/10/2018
6. Date on which issuer notified: 30/10/2018
7. Threshold(s) that is/are crossed or

reached: vi, vii
5%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of

shares



if possible using

the ISIN CODE
Situation previous

to the triggering

transaction
Resulting situation after the triggering transaction
Number

of

Shares
Number

of

Voting

Rights
Number

of shares
Number of voting

rights
% of  voting rights x
Direct Direct xi Indirect xii Direct Indirect
GB00BVV2KN49 4,837,772 5,112,772
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial

instrument
Expiration

date xiii
Exercise/

Conversion Period xiv
Number of voting

rights that may be

acquired if the

instrument is

exercised/ converted.
% of voting

rights
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial

instrument
Exercise price Expiration date xvii Exercise/

Conversion period xviii
Number of voting rights instrument refers to % of voting rights xix, xx
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting rights
5,112,772 5.1%
9. Chain of controlled undertakings through which the voting rights and/or the

financial instruments are effectively held, if applicable: xxi
Santander N&P UK Growth Unit Trust - 0.14%

Santander Max 70% Shares Unit Trust - 0.40%

Santander UK Growth Unit Trust - 3.73%

Santander Equity Income Unit Trust - 0.63%

Santander Dividend Income - 0.01%

Santander Max 30% Shares Income Portfolio - 0.03%

Santander Enhanced Income Portfolio - 0.22%

Santander Premium Fund UK Equities - 0.64%
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease

to hold:
12. Date on which proxy holder will cease to hold

voting rights:
13. Additional information:
14. Contact name: Veselin Georgiev Rangelov
15. Contact telephone number: +44 (0) 2 0791 40 729

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

HOLFSFFSFFASELF